U.S. Formulation Development Outsourcing Market Size & Outlook
Related Markets
U.S. formulation development outsourcing market highlights
- The U.S. formulation development outsourcing market generated a revenue of USD 8,870.4 million in 2024 and is expected to reach USD 14,143.2 million by 2030.
- The U.S. market is expected to grow at a CAGR of 8.2% from 2025 to 2030.
- In terms of segment, formulation development was the largest revenue generating service in 2024.
- Formulation Development is the most lucrative service segment registering the fastest growth during the forecast period.
Formulation development outsourcing market data book summary
| Market revenue in 2024 | USD 8,870.4 million |
| Market revenue in 2030 | USD 14,143.2 million |
| Growth rate | 8.2% (CAGR from 2025 to 2030) |
| Largest segment | Formulation development |
| Fastest growing segment | Formulation Development |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Preformulation, Formulation Development |
| Key market players worldwide | SGS, Intertek Group PLC, Recipharm, Lonza Group Ltd, Charles River Laboratories International Inc, Eurofins Scientific SE, Element Solutions Inc, Labcorp Holdings Inc, Thermo Fisher Scientific Inc, Catalent Inc |
Other key industry trends
- In terms of revenue, U.S. accounted for 23.8% of the global formulation development outsourcing market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. formulation development outsourcing market is projected to lead the regional market in terms of revenue in 2030.
- Mexico is the fastest growing regional market in North America and is projected to reach USD 531.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Formulation Development Outsourcing Market Scope
Formulation Development Outsourcing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| SGS | View profile | 10001+ | Geneva, Geneve, Switzerland, Europe | http://www.sgs.com/ |
| Element Solutions Inc | View profile | 5300 | 500 East Broward Boulevard, Suite 1860, Fort Lauderdale, FL, United States, 33394 | https://www.elementsolutionsinc.com |
| Recipharm | View profile | 1001-5000 | Jordbro, Stockholms Lan, Sweden, Europe | http://www.recipharm.com |
| Intertek Group PLC | View profile | 44000 | 33 Cavendish Square, London, United Kingdom, W1G 0PS | https://www.intertek.com |
| Catalent Inc | View profile | 17219 | 14 Schoolhouse Road, Somerset, NJ, United States, 08873 | https://www.catalent.com |
| Labcorp Holdings Inc | View profile | 67000 | 358 South Main Street, Burlington, NC, United States, 27215 | https://www.labcorp.com |
| Charles River Laboratories International Inc | View profile | 21400 | 251 Ballardvale Street, Wilmington, MA, United States, 01887 | https://www.criver.com |
| Eurofins Scientific SE | View profile | 61798 | 23 Val Fleuri, Luxembourg, Luxembourg, L-1526 | https://www.eurofins.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Lonza Group Ltd | View profile | 18000 | Muenchensteinerstrasse 38, Basel, Switzerland, CH-4002 | https://www.lonza.com |
U.S. formulation development outsourcing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to formulation development outsourcing market will help companies and investors design strategic landscapes.
Formulation development was the largest segment with a revenue share of 83.25% in 2024. Horizon Databook has segmented the U.S. formulation development outsourcing market based on preformulation, formulation development covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. accounts for a major share of clinical trial recruitment across the globe, with 20,781 trial studies being recruited within the country as of March 2023, according to clinicaltrails.gov. Along with branded and patented drug products, there is a strong demand for cost-effective generic and biosimilar compounds in this region.
For instance, according to a report published by Cardinal Health, in January 2022, around 33 FDA-approved biosimilars were available in the U.S., 21 of which were commercially available in the market. Thus, the increasing development and approval of novel biosimilars are expected to propel the demand for formulation development processes & outsourcing activities in the U.S., largely driving the market.
Furthermore, the country is reported to have a large population suffering from heart disease, with one person dying every 34 seconds, according to the Centers for Disease Control and Prevention. This raises the demand for effective therapeutic drugs with better bioavailability, which expands the opportunities for formulation development outsourcers.
Reasons to subscribe to U.S. formulation development outsourcing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. formulation development outsourcing market databook
-
Our clientele includes a mix of formulation development outsourcing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. formulation development outsourcing market , including forecasts for subscribers. This country databook contains high-level insights into U.S. formulation development outsourcing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. formulation development outsourcing market size, by service, 2018-2030 (US$M)
U.S. Formulation Development Outsourcing Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
